azoxymethane has been researched along with sirolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Chen, X; Chen, Z; He, X; He, Z; Ke, J; Lan, P; Wu, X; Yuan, R | 1 |
| Qiao, PF; Wang, FJ; Wang, Y; Zhang, HG; Zhao, ZX | 1 |
| Hong, Y; Jia, ML; Li, YT; Liu, XM; Liu, ZQ; Yan, PK; Zhu, WT | 1 |
3 other study(ies) available for azoxymethane and sirolimus
| Article | Year |
|---|---|
Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Cell Transformation, Neoplastic; Colitis; Colorectal Neoplasms; Cytokines; Dextran Sulfate; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Multiprotein Complexes; Signal Transduction; Sirolimus; STAT3 Transcription Factor; TOR Serine-Threonine Kinases | 2014 |
lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback regulatory loop with the miR‑34a/mTOR/SIRT1 pathway in colorectal cancer.
Topics: Aged; Animals; Azoxymethane; Cell Line, Tumor; Colon; Colorectal Neoplasms; Feedback, Physiological; Female; Gene Expression Regulation, Neoplastic; Humans; Macroautophagy; Male; MicroRNAs; Middle Aged; Neoplasms, Experimental; Rats; RNA, Long Noncoding; Signal Transduction; Sirolimus; Sirtuin 1; TOR Serine-Threonine Kinases | 2021 |
Rapamycin Liposomes Combined with 5-Fluorouracil Inhibits Angiogenesis and Tumor Growth of APC
Topics: Animals; Azoxymethane; Colitis; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Fluorouracil; Lipopolysaccharides; Liposomes; Mice; Mice, Inbred C57BL; Sirolimus | 2022 |